104 related articles for article (PubMed ID: 8721090)
41. Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer.
Hoffman RM
Methods Mol Biol; 2018; 1760():61-72. PubMed ID: 29572794
[TBL] [Abstract][Full Text] [Related]
42. [Chemosensitivity test for lung cancer].
Nishio K; Saijo N
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):225-31. PubMed ID: 2355692
[TBL] [Abstract][Full Text] [Related]
43. [Adjuvant chemotherapy in cancers of the gastrointestinal tract (GIT)].
Obrecht JP
Wien Med Wochenschr; 1988 Jul; 138(13):323-30. PubMed ID: 3055691
[TBL] [Abstract][Full Text] [Related]
44. In vitro chemosensitivity testing in acute leukemias. Results of a retrospective study.
Lepri E; Liberati M; Menconi E; Santucci A; Piselli F; Barzi A
Anticancer Res; 1990; 10(6):1735-8. PubMed ID: 2285251
[TBL] [Abstract][Full Text] [Related]
45. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
46. [Principles of multi-modality therapy in tumors of the gastrointestinal tract].
Siewert JR; Fink U
Chirurg; 1992 Apr; 63(4):242-50. PubMed ID: 1597086
[No Abstract] [Full Text] [Related]
47. [Experimental and clinical studies on chemosensitivity tests of anticancer agents by human tumor clonogenic assay].
Hirabayashi N
Nihon Geka Gakkai Zasshi; 1986 Aug; 87(8):834-45. PubMed ID: 3092023
[TBL] [Abstract][Full Text] [Related]
48. The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer.
Kawamura H; Ikeda K; Takiyama I; Terashima M
Eur J Cancer; 1997 May; 33(6):960-6. PubMed ID: 9291821
[TBL] [Abstract][Full Text] [Related]
49. [Chemosensitivity testing in ovarian cancer--prospects for the future].
Pogońska P; Wydra D; Serkies K; Kobierski J; Łojkowska A
Ginekol Pol; 2014 Sep; 85(9):695-8. PubMed ID: 25322542
[TBL] [Abstract][Full Text] [Related]
50. Chemosensitivity testing--present and future in Japan.
Kubota T; Otani Y; Furukawa T; Hasegawa H; Watanabe M; Kitajima M
Recent Results Cancer Res; 2003; 161():231-41. PubMed ID: 12528811
[TBL] [Abstract][Full Text] [Related]
51. [New developments in chemotherapy of gastrointestinal carcinomas].
Hartung G
Onkologie; 2001 Sep; 24 Suppl 5():10-5. PubMed ID: 11600807
[No Abstract] [Full Text] [Related]
52. Chemosensitivity assays: still eyeing the clinic.
Jenks S
J Natl Cancer Inst; 2012 Dec; 104(23):1775-7. PubMed ID: 23213182
[No Abstract] [Full Text] [Related]
53. A novel in vitro chemosensitivity test using materials collected by endoscopic biopsy.
Hirai T; Kawano K; Hirabayashi N; Nishiyama M; Yamashita Y; Mukaida H; Iwata T; Toge T
Anticancer Drugs; 1991 Jun; 2(3):269-74. PubMed ID: 1802022
[TBL] [Abstract][Full Text] [Related]
54. Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy.
Leone LA; Meitner PA; Myers TJ; Grace WR; Gajewski WH; Fingert HJ; Rotman B
Cancer Invest; 1991; 9(5):491-503. PubMed ID: 1933482
[TBL] [Abstract][Full Text] [Related]
55. Predictive chemosensitivity testing in malignant melanoma: reliable methodology--ineffective drugs.
Tveit KM; Gundersen S; Høie J; Pihl A
Br J Cancer; 1988 Dec; 58(6):734-7. PubMed ID: 3224078
[TBL] [Abstract][Full Text] [Related]
56. Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis.
Blom K; Nygren P; Larsson R; Andersson CR
SLAS Technol; 2017 Jun; 22(3):306-314. PubMed ID: 28378608
[TBL] [Abstract][Full Text] [Related]
57. [Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics].
Král V; Hajdúch M; Neoral C; Klein J; Mihál V; Orel M; Aujeský R; Vyslouzil K; Cwiertka K; Kolek V; Nosková V
Rozhl Chir; 2000 Mar; 79(3):134-8. PubMed ID: 10838948
[TBL] [Abstract][Full Text] [Related]
58. Histoculture and the immunodeficient mouse come to the cancer clinic - rational approaches to individualizing cancer-therapy and new drug-evaluation (review).
Hoffman R
Int J Oncol; 1992 Sep; 1(4):467-74. PubMed ID: 21584568
[TBL] [Abstract][Full Text] [Related]
59. New drug development in gastrointestinal-tract cancer.
Garzon FT; Berger MR; Bischoff H; Schmähl D
Recent Results Cancer Res; 1988; 110():286-96. PubMed ID: 3406507
[No Abstract] [Full Text] [Related]
60. Upper gastrointestinal malignancies: a new era in clinical colorectal cancer.
Hawkes E; Chau I; Ilson DH; Cunningham D
Clin Colorectal Cancer; 2009 Oct; 8(4):185-9. PubMed ID: 19822506
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
